日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Biphasic lipid extraction from microalgae after PEF-treatment reduces the energy demand of the downstream process

经脉冲电场处理后从微藻中提取双相脂质可降低下游工艺的能耗。

Papachristou, Ioannis; Nazarova, Natalja; Wüstner, Rüdiger; Lina, Robin; Frey, Wolfgang; Silve, Aude

BCL-XL-targeting antibody-drug conjugates are active in preclinical models and mitigate on-mechanism toxicity of small-molecule inhibitors

靶向BCL-XL的抗体药物偶联物在临床前模型中具有活性,并能减轻小分子抑制剂的靶向毒性。

Andrew S Judd ,Bhupinder Bawa ,Wayne R Buck ,Zhi-Fu Tao ,Yingchun Li ,Michael J Mitten ,Milan Bruncko ,Nathaniel Catron ,George Doherty ,Kenneth R Durbin ,Brian Enright ,Robin Frey ,Deanna Haasch ,Sandra Haman ,Anthony R Haight ,Tracy A Henriques ,James Holms ,Kamel Izeradjene ,Russell A Judge ,Gary J Jenkins ,Aaron Kunzer ,Joel D Leverson ,Ruth L Martin ,Diya Mitra ,Scott Mittelstadt ,Lorne Nelson ,Paul Nimmer ,Joann Palma ,Richard Peterson ,Darren C Phillips ,Sherry L Ralston ,Saul H Rosenberg ,Xiaoqiang Shen ,Xiaohong Song ,Kedar S Vaidya ,Xilu Wang ,Jin Wang ,Yu Xiao ,Haichao Zhang ,Xinxin Zhang ,Eric A Blomme ,Erwin R Boghaert ,John C Kalvass ,Andrew Phillips ,Andrew J Souers

Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours

发现针对谱系特异性肿瘤的选择性催化 p300/CBP 抑制剂

Loren M Lasko, Clarissa G Jakob, Rohinton P Edalji, Wei Qiu, Debra Montgomery, Enrico L Digiammarino, T Matt Hansen, Roberto M Risi, Robin Frey, Vlasios Manaves, Bailin Shaw, Mikkel Algire, Paul Hessler, Lloyd T Lam, Tamar Uziel, Emily Faivre, Debra Ferguson, Fritz G Buchanan, Ruth L Martin, Maricel